Double-blind Comparative Study of Epinastine Dry Syrup with Ketotifen Dry Syrup in Children with Perennial Allergic Rhinitis

Practica Otologica, Supplement

Volumn , Issue 114, 2004, Pages 1-21

  Okuda, Minoru ^a   Okubo, Kimihiro ^b  

^a Japan Allergy and Asthma Clinic   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Children with perennial allergic rhinitis; Double blind study; Epinastine dry syrup; Ketotifen dry syrup

Indexed keywords

EPINASTINE; KETOTIFEN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE OBSTRUCTION; PERENNIAL RHINITIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SNEEZING; SOMNOLENCE; SYRUP;

EID: 0942287760     PISSN: 09121870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bechtel WD and Mierau J: Biochemical characterization of WAL801C1. 1985.
2. Bechtel WD and Mierau J: Astemizol und Terfenadin anhand biochemischer in vitro-Ergebnisse. 1986.
3. Fuegner A, Bechtel WD, Kuhn FJ, et al.: In vitro and in vivo studies of the non-sedating antihistamine epinastine. Arzneimittelforschung 38: 1446-1453, 1988.
4. Kamei C, Mio M, Kitazumi K, et al.: Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II); antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects. Immunopharmacol Immunotoxicol 14: 207-218, 1992.
5. Misawa M and Kanai Y: Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. Arzneimittelforschung 41: 1145-1149, 1991.
6. Kamei C, Akagi M, Mio M, et al.: Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I); elucidation of the mechanism for histamine release inhibition. Immunopharmacol Immunotoxicol 14: 191-205, 1992.
7. Tasaka K, Akagi M, Izushi K, et al.: Antiallergic effect of epinastine: the elucidation of the mechanism. Ǒyô Yakuri/Pharmacometrics 39: 365-373, 1990.
8. Mita H and Shida T: Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes. Arzneimittelforschung 45: 36-40, 1995.
9. Kohyama T, Takizawa H, Akiyama N, et al.: A novel antiallergic drug epinastine inhibits IL-8 release from human eosinophils. Biochem Biophys Res Commun 230: 125-128, 1997.
10. Tasaka K, Kamei C, Nakano S, et al.: Effect of epinastine, a new antiallergic agent, on the central nervous system. 38: 53-62, 1989.
11. Yokoyama H, Sato M, Iimura K, et al.: Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats. Neurosci Lett 217: 194-196, 1996.
12. Ohara N, Takizawa M, Yokota S, et al.: General pharmacology of epinastine hydrochloride (WAL 801 CL), an antiallergic agent. Jpn Pharmacol Ther 20: 63-90, 1992.